Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 The volatile nature of pneumococcal serotype epidemiology: potential for misinterpretation.

× No keyword cloud information.

16 in total

Review 1. Pneumococcal polysaccharide conjugate vaccine (13-valent, adsorbed) [Prevenar 13(®)]: profile report.

Authors: Sean T Duggan
Journal: Paediatr Drugs Date: 2012-02-01 Impact factor: 3.022

2. Long-term trends in invasive pneumococcal disease in Manitoba, Canada.

Authors: Salaheddin M Mahmud; Hasantha Sinnock; Luiz C Mostaço-Guidolin; Gurpreet Pabla; Aleksandra K Wierzbowski; Songul Bozat-Emre
Journal: Hum Vaccin Immunother Date: 2017-05-11 Impact factor: 3.452

Review 3. Pneumococcal polysaccharide conjugate vaccine (13-valent, adsorbed) [prevenar 13®].

Authors: Sean T Duggan
Journal: Drugs Date: 2010-10-22 Impact factor: 9.546

4. Dynamic models of pneumococcal carriage and the impact of the Heptavalent Pneumococcal Conjugate Vaccine on invasive pneumococcal disease.

Authors: Alessia Melegaro; Yoon Hong Choi; Robert George; W John Edmunds; Elizabeth Miller; Nigel J Gay
Journal: BMC Infect Dis Date: 2010-04-08 Impact factor: 3.090

5. Assessment of Streptococcus pneumoniae pilus islet-1 prevalence in carried and transmitted isolates from mother-infant pairs on the Thailand-Burma border.

Authors: P Turner; S Melchiorre; M Moschioni; M A Barocchi; C Turner; W Watthanaworawit; N Kaewcharernnet; F Nosten; D Goldblatt
Journal: Clin Microbiol Infect Date: 2011-11-16 Impact factor: 8.067

6. 7-Valent pneumococcal conjugate vaccination in England and Wales: is it still beneficial despite high levels of serotype replacement?

Authors: Yoon Hong Choi; Mark Jit; Nigel Gay; Nick Andrews; Pauline A Waight; Alessia Melegaro; Robert George; Elizabeth Miller
Journal: PLoS One Date: 2011-10-14 Impact factor: 3.240

7. The serotype distribution among healthy carriers before vaccination is essential for predicting the impact of pneumococcal conjugate vaccine on invasive disease.

Authors: Stefan Flasche; Olivier Le Polain de Waroux; Katherine L O'Brien; W John Edmunds
Journal: PLoS Comput Biol Date: 2015-04-16 Impact factor: 4.475

8. Serotype dynamics of invasive pneumococcal disease post-PCV7 and pre-PCV13 introduction in North East England.

Authors: K E Chapman; D Wilson; R Gorton
Journal: Epidemiol Infect Date: 2012-05-08 Impact factor: 4.434

Review 9. Towards New Broader Spectrum Pneumococcal Vaccines: The Future of Pneumococcal Disease Prevention.

Authors: Lucia H Lee; Xin-Xing Gu; Moon H Nahm
Journal: Vaccines (Basel) Date: 2014-02-14

10. Serotype-specific changes in invasive pneumococcal disease after pneumococcal conjugate vaccine introduction: a pooled analysis of multiple surveillance sites.

Authors: Daniel R Feikin; Eunice W Kagucia; Jennifer D Loo; Ruth Link-Gelles; Milo A Puhan; Thomas Cherian; Orin S Levine; Cynthia G Whitney; Katherine L O'Brien; Matthew R Moore
Journal: PLoS Med Date: 2013-09-24 Impact factor: 11.069